Online citations, reference lists, and bibliographies.
← Back to Search

Comparison Of The Gastrointestinal Anatomy, Physiology, And Biochemistry Of Humans And Commonly Used Laboratory Animals

T. Kararli
Published 1995 · Chemistry, Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In addition to metabolic differences, the anatomical, physiological, and biochemical differences in the gastrointestinal (G.I.) tract of the human and common laboratory animals can cause significant variation in drug absorption from the oral route. Among the physiological factors, pH, bile, pancreatic juice, and mucus and fluid volume and content can modify dissolution rates, solubility, transit times, and membrane transport of drug molecules. The microbial content of the G.I. tract can significantly affect the reductive metabolism and enterohepatic circulation of drugs and colonic delivery of formulations. The transit time of dosage forms can be significantly different between species due to different dimensions and propulsive activities of the G.I. tract. The lipid/protein composition of the enterocyte membrane along the G.I. tract can alter binding and passive, active, and carrier‐mediated transport of drugs. The location and number of Peyer's patches can also be important in the absorption of large molecules and particulate matter.
This paper references
10.1152/AJPGI.1990.258.6.G856
Transit of solids through the human colon: regional quantification in the unprepared bowel.
M. Proano (1990)
10.1016/0005-2736(86)90154-9
A comparison of brush-border membranes prepared from rabbit small intestine by procedures involving Ca2+ and Mg2+ precipitation.
H. Aubry (1986)
10.1159/000198003
Functional and structural characteristics of the jejunum and ileum in the dog and the rat.
J. W. Robinson (1977)
10.1007/978-1-4613-2745-5_11
Alternative Approaches to Oral Controlled Drug Delivery: Bioadhesives and In-Situ Systems
K. Park (1984)
10.1136/gut.27.8.886
Transit of pharmaceutical dosage forms through the small intestine.
S. Davis (1986)
10.1016/0005-2760(74)90253-7
Lipid components of two different regions of an intestinal epithelial cell membrane of mouse.
Kawai Koichi (1974)
10.1016/0005-2736(73)90478-1
On the preparation and some properties of closed membrane vesicles from hog duodenal and jejunal brush border.
D. Louvard (1973)
10.1093/ajcn/31.10.S161
Physiological implications of microbial digestion in the large intestine of mammals: relation to dietary factors.
C. E. Stevens (1978)
10.1016/0005-2736(85)90189-0
Regional differences in the lipid composition and fluidity of rat colonic brush-border membranes.
T. Brasitus (1985)
A comparison of small intestinal transit time between the rat and the guinea-pig.
G. Pettersson (1976)
10.1679/AOHC1950.40.407
A Qualitative and Quantitative Morphologic Study of Peyer's Patches of the Mouse
K. Abe (1977)
[Comparative anatomo-surgical study on the biliary and pancreatic excretory apparatus of the most common experimental animals].
A. Farinon (1975)
10.1016/0003-9861(85)90054-2
Alterations in the physical state and composition of brush border membrane lipids of rat enterocytes during differentiation.
T. Brasitus (1985)
10.1016/0005-2736(88)90055-7
Membrane fluidity and lipid composition of rat small intestinal brush-border membranes during postnatal maturation.
C. Hübner (1988)
10.1002/path.1700890112
OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION.
H. W. Smith (1965)
Targeting in the gastrointestinal tract: new approaches.
W. Ritschel (1991)
10.1038/ICB.1978.3
Studies on the brush border membrane on mouse duodenum: lipids.
T. Billington (1978)
10.1083/JCB.58.1.189
INTESTINAL TRANSPORT OF ANTIBODIES IN THE NEWBORN RAT
R. Rodewald (1973)
10.1002/JPS.2600810907
Rate-limiting steps in oral absorption of a leucotriene D4 antagonist in the beagle dog.
T. Kararli (1992)
10.1007/978-1-4684-5344-7_29
Canine Peyer's patches: macroscopic, light microscopic, scanning electron microscopic and immunohistochemical investigations.
H. HogenEsch (1987)
10.1016/0304-4157(91)90016-P
Structure-function relationships in intestinal brush border membranes.
P. Proulx (1991)
Animal models for oral drug absorption
J. Dressman (1991)
10.1016/B978-0-12-742150-6.50008-6
CHAPTER 3 – Anatomy, Physiology, and Biochemistry of the Rabbit
Carlos Kozma (1974)
10.1136/gut.21.3.249
Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection.
A. Allen (1980)
10.1016/0165-2427(90)90020-S
Ultrastructure and alkaline phosphatase activity of the dome epithelium of canine Peyer's patches.
H. HogenEsch (1990)
Gastrointestinal absorption of drugs.
Kararli Tt (1989)
10.1016/0005-2760(73)90183-5
Plasma membrane and mucosal glycosphingolipids in the rat intestine.
G. Forstner (1973)
Morphologic characteristics of the epithelial surface of aggregated lymphoid follicles (Peyer's patches) in the small intestine of newborn gnotobiotic calves and pigs.
A. Torres-Medina (1981)
10.1136/gut.14.6.475
A double isotope technique for the evaluation of drug action on gastric evacuation and small bowel propulsion studied in the rat
F. Nilsson (1973)
10.1258/002367789780886911
Comparative morphology of the stomach of some laboratory mammals
N. G. Ghoshal (1989)
10.1042/CS0550253
Bile secretion and bile composition in the freely moving, unanaesthetized rat with a permanent biliary drainage: influence of food intake on bile flow.
R. Vonk (1978)
10.1248/CPB.38.1755
Measurement of gastric pH during digestion of a solid meal in dogs.
I. Yamada (1990)
10.1016/0005-2736(84)90284-0
Lipid composition and fluidity of rat enterocyte basolateral membranes. Regional differences.
T. Brasitus (1984)
10.1136/gut.30.12.1667
Intestinal brush border revisited.
R. Holmes (1989)
10.1159/000114728
Liver function and gastric acid secretion in parkinsonian patients under prolonged treatment with L-dopa and a peripheral decarboxylase inhibitor.
M. Streifler (1976)
10.1016/0005-2736(81)90245-5
Microvillus membrane vesicles from pig small intestine. Purity and lipid composition.
K. Christiansen (1981)
10.1146/ANNUREV.PA.18.040178.002515
Biochemical pharmacology of the intestinal flora.
P. Goldman (1978)
10.1016/0047-7206(71)90041-0
Scanning electron microscope observations of mammalian intestinal villi, intervillus floor and crypt tubules
A. Taylor (1971)
10.1136/gut.6.3.225
Number, size, and distribution of Peyer's patches in the human small intestine
J. S. Cornes (1965)
10.1016/S0016-5085(84)80069-4
Structural features of and cholesterol distribution in M-cell membranes in guinea pig, rat, and mouse Peyer's patches.
J. Madara (1984)
10.1016/S0016-5085(74)80102-2
Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles.
R. L. Owen (1974)
10.1159/000197800
The epithelial surface of the monkey gastrointestinal tract. A scanning electron-microscopic study.
J. Burke (1976)
10.1007/978-3-642-69505-6_1
Morphology of the Intestinal Mucosa
K. Carr (1984)
10.1016/0005-2736(84)90378-X
Lipid fluidity and composition of intestinal microvillus membranes isolated from rats of different ages.
T. Brasitus (1984)
10.1016/0005-2736(80)90335-1
Rabbit small intestinal brush border membrane preparation and lipid composition.
H. Hauser (1980)
10.1152/AJPGI.1991.260.1.G13
Unprepared human colon does not discriminate between solids and liquids.
M. Proano (1991)
10.1007/978-3-642-71851-9_3
Peyer's patches and the early development of B lymphocytes.
J. Reynolds (1987)
Postnatal development and lymphocyte production of jejunal and ileal Peyer's patches in normal and gnotobiotic pigs.
R. Pabst (1988)
10.1021/BI00553A035
Lipid dynamics and lipid-protein interactions in rat enterocyte basolateral and microvillus membranes.
T. Brasitus (1980)
10.1248/CPB.27.2468
Interaction of drugs with bile components. I. Effects of bile salts on the dissolution behavior of indomethacin and phenylbutazone.
S. Miyazaki (1979)
10.1152/AJPENDO.1977.232.2.E186
Gastric emptying and secretion in the rhesus monkey.
A. Dubois (1977)
10.1152/AJPGI.1985.248.2.G200
Intestinal membrane lipid composition and fluidity during development in the rat.
S. Schwarz (1985)
10.1016/0008-8749(70)90038-9
Peyer's patches: morphologic studies.
W. Faulk (1970)
10.1099/00222615-4-4-451
Intestinal bacteria and the hydrolysis of glycosidic bonds.
G. Hawksworth (1971)
10.1016/0169-409X(88)90022-1
Some biological issues in oral, controlled drug delivery
P. Gruber (1987)
10.1016/B978-0-12-592550-1.50016-7
CHAPTER 10 – The Significance of the Gut Flora in Safety Testing of Food Additives
B. Drasar (1970)
10.1016/0169-409X(91)90051-D
Colon-specific drug delivery
D. Friend (1991)
10.1159/000114832
Polygraphic study of periodic breathing and hypersomnolence in a patient with severe hypothyroidism.
T. Yamamoto (1977)
Glycosphingolipids and ceramide distribution in brush border and basolateral membranes of the rat mature intestinal cells [proceedings].
Bouhours Jf (1978)
10.1016/S0016-5085(84)80169-9
Lipid composition and membrane fluidity in the small intestine of the developing rabbit.
S. Schwarz (1984)
10.1139/O65-128
Osmolality of blood and intestinal contents in the pig, guinea pig, and Ascaris lumbricoides.
R. Harpur (1965)
10.1258/002367787781268693
Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting
F. Ward (1987)
10.1002/AR.1090180105
The extrahepatic biliary tract in common domestic and laboratory animals
F. Mann (1920)



This paper is referenced by
10.21037/TGH.2020.02.02
Barrier therapies supporting the biology of the mucosal barrier- medical devices for common clinical mucosal disorders
R. Mccullough (2020)
10.3748/WJG.V12.I7.1092
Cloning and characterization of porcine aquaporin 1 water channel expressed extensively in gastrointestinal system.
Shun-Ying Jin (2006)
10.1016/j.xphs.2020.06.013
Understanding Pharmacokinetic Disconnect in Preclinical Species for 4-Aminoquinolines: Consequences of Low Permeability and High P-glycoprotein Efflux Ratio on Rat and Dog Oral Pharmacokinetics.
M. K. Mahajan (2020)
Influence of excipients on stabilisation of amorphous cefuroxime axetil under process conditions of compression and coating.
Nadia Abder Rahman Ali Ghazal (2005)
10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I23.30
Emerging trends in oral delivery of peptide and protein drugs.
R. Mahato (2003)
10.1016/J.ADDR.2007.10.012
Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
C. O'Driscoll (2008)
10.1002/JPS.21118
Biorelevant refinement of the Caco-2 cell culture model to assess efficacy of paracellular permeability enhancers.
Timothy K. Tippin (2008)
10.1292/JVMS.71.463
Histoplanimetrical study on the relationship between the cell kinetics of villous columnar epithelial cells and the proliferation of indigenous bacteria in rat small intestine.
Wang-Mei Qi (2009)
10.1258/la.2009.009112
Surface area assessment of the murine intestinal tract as a prerequisite for oral dose translation from mouse to man
C. Casteleyn (2010)
10.1007/978-1-4614-1004-1_4
Animal Model Systems Suitable for Controlled Release Modeling
S. C. Sutton (2011)
SÍNTESE E CARACTERIZAÇÃO DE HIDROGÉIS DE AMIDO RETROGRADADO E GOMA GELANA UTILIZADOS COMO MATRIZ EM SISTEMAS DE LIBERAÇÃO CÓLON ESPECÍFICA DE FÁRMACOS
Câmpus de Araraquara (2014)
10.1016/j.jconrel.2012.06.003
Microencapsulation of probiotics for gastrointestinal delivery.
M. Cook (2012)
10.1016/S1056-8719(00)00095-2
Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.
R. Leadley (2000)
Development of the Enteric Nervous System in a Porcine Model of Early Life Stress: Implications for Long-Term Intestinal Disease Susceptibility.
Julia Elise Medland (2015)
10.3390/toxins7061945
Nivalenol Has a Greater Impact than Deoxynivalenol on Pig Jejunum Mucosa in Vitro on Explants and in Vivo on Intestinal Loops
Sophal Cheat (2015)
10.1016/j.cell.2016.05.054
Forces Driving Chaperone Action
P. Koldewey (2016)
Characterizing Intestinal Glucose Absorption in Mammalian Pig and Aquatic Species Tilapia and Trout
Marina Subramaniam (2019)
DESIGN AND SYNTHESIS OF STIMULI-RESPONSIVE POLYMERIC NANOGELS TOWARDS THERAPEUTIC TRANSLATION
Mallory R Gordon (2018)
10.1016/j.fct.2018.04.008
Assessing the effects of silver nanoparticles on monolayers of differentiated Caco-2 cells, as a model of intestinal barrier.
L. Vila (2018)
10.4161/gmic.23188
Dissecting the role of milk components on gut microbiota composition
E. A. Maga (2013)
10.1111/j.2042-7158.1998.tb06187.x
The Effect of a Drug‐delivery System Consisting of Soybean Phosphatidyl Choline and Medium‐chain Monoacylglycerol on the Intestinal Permeability of Hexarelin in the Rat
U. Fagerholm (1998)
10.1016/j.scitotenv.2018.12.317
Bioaccessibility and relative oral bioavailability of cobalt and nickel in residential soil and dust affected by metal grinding operations.
M. Suh (2019)
10.1016/J.AQUACULTURE.2015.02.032
Characteristics of digestive processes in Atlantic salmon (Salmo salar). Enzyme pH optima, chyme pH, and enzyme activities
Å. Krogdahl (2015)
10.3390/antiox9070610
The Potential of Lactobacillus spp. for Modulating Oxidative Stress in the Gastrointestinal Tract
Yanzhuo Kong (2020)
10.1016/j.yrtph.2018.04.016
An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non‐genotoxic initiating events
D. Proctor (2018)
10.1016/j.addr.2015.03.007
Delivery strategies to enhance oral vaccination against enteric infections.
Christopher J. H. Davitt (2015)
Study of Fucoidan Digestibility via an in Vitro Digestion System
Y. Cao (2015)
10.1097/CAD.0b013e32835006f5
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer
Alain G. Musende (2012)
10.1002/jps.24270
Evaluation of the use of Göttingen minipigs to predict food effects on the oral absorption of drugs in humans.
M. Christiansen (2015)
10.1124/dmd.106.012013
Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
S. Stern (2007)
10.1007/978-1-349-14416-7_10
Drug Absorption and Routes of Administration
A. Florence (1998)
10.1016/S0378-5173(01)00831-6
Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation.
C. Shishoo (2001)
See more
Semantic Scholar Logo Some data provided by SemanticScholar